Royalty Pharma PLC - Common Stock (RPRX)

CUSIP: 76028H209

Q4 2017 13F Holders as of 31 Dec 2017

Holder snapshot 6 signals
Share change
-320,591
SEC-reported price per share
$0.66
Number of holders
23
Value change
-$77,028
Number of buys
10
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
429,232,034

Security key

76028H209

Report period

Q4 2017

Institutions

23

Top holders

10

Ownership snapshot

Top reported holders of RPRX - Royalty Pharma PLC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
0/15
Latest evidence
30 Sep 2017
13F Highest disclosed value: $476,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FMR LLC has the largest disclosed position value at $476K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Disclosed position value Top 5
FMR LLC $476K
RENAISSANCE TECHNOLOGIES LLC $359K
VANGUARD GROUP INC $256K
BlackRock Finance, Inc. $219K
Allegis Investment Advisors, LLC $126K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F
Company
13F
—
denominator unverified
$476,000
1,486,144 shares
— 30 Sep 2017
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$359,000
1,122,013 shares
— 30 Sep 2017
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$256,000
801,737 shares
— 30 Sep 2017
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$219,000
686,324 shares
— 30 Sep 2017
Allegis Investment Advisors, LLC
13F
Company
13F
—
denominator unverified
$126,000
394,041 shares
— 30 Sep 2017
GENERAL AMERICAN INVESTORS CO INC
13F
Company
13F
—
denominator unverified
$76,000
237,504 shares
— 30 Sep 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
23
Shares
5,043,064
Rows available
23
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2017 vs Q3 2017 Across Filers

Q3 2017 holders
21
Q4 2017 holders
23
Holder diff
2
Investor Q3 2017 Shares Q4 2017 Shares Share Diff Share Chg % Q3 2017 value Q4 2017 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .